Skip to content

Drug interactions

Glyburide + Ivacaftor

Severity: Minor

Glyburide and Ivacaftor: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ivacaftor and its metabolite weakly inhibit P-gp and may modestly increase glyburide exposure. Glyburide is not a clinically significant CYP3A4 inhibitor, so ivacaftor exposure is unlikely to change. The main concern is mild potentiation of glucose lowering.

What this interaction means in plain words

Glyburide and Ivacaftor have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Glyburide belongs to Endocrine; Ivacaftor belongs to Miscellaneous.

Evidence level: Low

Why it happens

Ivacaftor weakly inhibits P-gp efflux, potentially increasing glyburide absorption and concentrations.

What to do

Monitor blood glucose when ivacaftor is started, particularly in patients with cystic fibrosis-related diabetes, and adjust the glyburide dose if needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glyburide and Ivacaftor, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Glyburide with Ivacaftor?

MediHelp rates the interaction as minor. Glyburide and Ivacaftor have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ivacaftor and its metabolite weakly inhibit P-gp and may modestly increase glyburide exposure. Glyburide is not a clinically significant CYP3A4 inhibitor, so ivacaftor exposure is unlikely to change. The main concern is mild potentiation of glucose lowering.

How serious is the interaction between Glyburide and Ivacaftor?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when ivacaftor is started, particularly in patients with cystic fibrosis-related diabetes, and adjust the glyburide dose if needed.

What other medicines interact with Glyburide?

MediHelp also lists interactions of Glyburide with, for example, Bosentan, Cholic acid, Ciprofloxacin. The full list is on the Glyburide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in